Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, February 11, 2021
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
Anupam Rama Upgraded (ANAB) to Buy and Increased Target to $40 on, Feb 11th, 2021
Anupam Rama of JP Morgan, Upgraded "AnaptysBio, Inc." (ANAB) to Buy and Increased Target from $19 to $40 on, Feb 11th, 2021.
Anupam has made no other calls on ANAB in the last 4 months.
There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, 0 agree with Anupam's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Anupam
- David Nierengarten of "Wedbush" Upgraded from Hold to Buy and Increased Target to $35 on, Tuesday, October 27th, 2020
- Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $36 on, Wednesday, October 14th, 2020
